Orthocell Ltd has released a press release.
Q4 FY26 ASX Investor Presentation
Earlier from Orthocell
- Orthocell Appoints Thailand Distributor for Remplir
- Remplir™: Australian Nerve Repair Device Supports Victims of War in Ukraine
- First Sales of Remplir Achieved in US$75m Canadian Market
- Compelling 90% Success Rate for Remplir in Real World Study